Cargando…

Predicting cancer relapse following lung stereotactic radiotherapy: an external validation study using real-world evidence

PURPOSE: For patients receiving lung stereotactic ablative radiotherapy (SABR), evidence suggests that high peritumor density predicts an increased risk of microscopic disease (MDE) and local-regional failure, but only if there is low or heterogenous incidental dose surrounding the tumor (GTV). A da...

Descripción completa

Detalles Bibliográficos
Autores principales:	Davey, Angela, Thor, Maria, van Herk, Marcel, Faivre-Finn, Corinne, Rimner, Andreas, Deasy, Joseph O., McWilliam, Alan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10369005/ https://www.ncbi.nlm.nih.gov/pubmed/37503315 http://dx.doi.org/10.3389/fonc.2023.1156389

Ejemplares similares

Optimising use of 4D-CT phase information for radiomics analysis in lung cancer patients treated with stereotactic body radiotherapy
por: Davey, Angela, et al.
Publicado: (2021)

Radial Data Mining to Identify Density–Dose Interactions That Predict Distant Failure Following SABR
por: Davey, Angela, et al.
Publicado: (2022)

Role of Real-World Data in Assessing Cardiac Toxicity After Lung Cancer Radiotherapy
por: Abravan, Azadeh, et al.
Publicado: (2022)

Heart dose and cardiac comorbidities influence death with a cardiac cause following hypofractionated radiotherapy for lung cancer
por: Banfill, Kathryn, et al.
Publicado: (2022)

Automated gross tumor volume contour generation for large‐scale analysis of early‐stage lung cancer patients planned with 4D‐CT
por: Davey, Angela, et al.
Publicado: (2020)

Impact of small residual setup errors after image guidance on heart dose and survival in non-small cell lung cancer treated with curative-intent radiotherapy
por: Johnson-Hart, Corinne, et al.
Publicado: (2020)

Stereotactic Body Radiotherapy for Lymph Node Oligometastases: Real-World Evidence From 90 Consecutive Patients
por: Burkon, Petr, et al.
Publicado: (2021)

External validation of pulmonary radiotherapy toxicity models for ultracentral lung tumors
por: Chen, Ishita, et al.
Publicado: (2022)

Comparison of intensity modulated radiotherapy plan optimisation methods for a 1.5 T MR‐Linac
por: Chuter, Robert, et al.
Publicado: (2018)

Radiation-Induced Dyspnea in Lung Cancer Patients Treated with Stereotactic Body Radiation Therapy
por: Cella, Laura, et al.
Publicado: (2021)

Predictive Modeling of Thoracic Radiotherapy Toxicity and the Potential Role of Serum Alpha-2-Macroglobulin
por: von Reibnitz, Donata, et al.
Publicado: (2020)

Image Based Data Mining Using Per-voxel Cox Regression
por: Green, Andrew, et al.
Publicado: (2020)

Study protocol for the SARON trial: a multicentre, randomised controlled phase III trial comparing the addition of stereotactic ablative radiotherapy and radical radiotherapy with standard chemotherapy alone for oligometastatic non-small cell lung cancer
por: Conibear, John, et al.
Publicado: (2018)

Radiotherapy or chemotherapy: a real-world study of the first-time relapsed and refractory primary central nervous system lymphoma
por: Yang, Yu, et al.
Publicado: (2023)

Quantitative evaluation of 4D Cone beam CT scans with reduced scan time in lung cancer patients
por: Bryce-Atkinson, Abigail, et al.
Publicado: (2019)

Adaptive hypofractionted and stereotactic body radiotherapy for lung tumors with real-time MRI guidance
por: Bryant, John M., et al.
Publicado: (2023)

Advances in Radiobiology of Stereotactic Ablative Radiotherapy
por: Qiu, Bin, et al.
Publicado: (2020)

Dose outside of the prostate is associated with improved outcomes for high-risk prostate cancer patients treated with brachytherapy boost
por: Shortall, Jane, et al.
Publicado: (2023)

Treatment Interruptions During Stereotactic Body Radiotherapy for Prostate Cancer
por: Pepin, Abigail N., et al.
Publicado: (2022)

Stereotactic Body Radiotherapy for the Treatment of Renal Tumors()
por: Hanzly, Michael, et al.
Publicado: (2014)

Editorial: Stereotactic body radiotherapy for prostate cancer
por: Kishan, Amar U., et al.
Publicado: (2022)

Editorial: Stereotactic body radiotherapy for lung cancer
por: Liu, An, et al.
Publicado: (2023)

Cardio-pulmonary substructure segmentation of radiotherapy computed tomography images using convolutional neural networks for clinical outcomes analysis
por: Haq, Rabia, et al.
Publicado: (2020)

Stereotactic Body Radiotherapy for Hepatocellular Carcinoma Resulting in a Durable Relapse-Free Survival: A Case Report
por: Francis, Samual, et al.
Publicado: (2016)

Editorial: Novel Applications of Stereotactic Body Radiotherapy (SBRT)
por: Kotecha, Rupesh, et al.
Publicado: (2021)

Efficacy of Stereotactic Body Radiotherapy in Patients With Hepatocellular Carcinoma Not Suitable for Transarterial Chemoembolization (HERACLES: HEpatocellular Carcinoma Stereotactic RAdiotherapy CLinical Efficacy Study)
por: Brunner, Thomas B., et al.
Publicado: (2021)

Re-Irradiation With Stereotactic Body Radiotherapy for In-Field Recurrence of Pancreatic Cancer After Prior Stereotactic Body Radiotherapy: Analysis of 24 Consecutive Cases
por: Shen, Yuxin, et al.
Publicado: (2021)

Stereotactic radiotherapy for soft tissue and bone sarcomas: real-world evidence
por: Spałek, Mateusz Jacek, et al.
Publicado: (2022)

Real-World Practice of Hypofractionated Radiotherapy in Patients With Invasive Breast Cancer
por: Chen, Fang, et al.
Publicado: (2022)

Impact of Introducing Intensity Modulated Radiotherapy on Curative Intent Radiotherapy and Survival for Lung Cancer
por: Fornacon-Wood, Isabella, et al.
Publicado: (2022)

RONC-06. Stereotactic radiosurgery and stereotactic radiotherapy for pediatric brain metastases or recurrences
por: McGovern, Susan, et al.
Publicado: (2022)

Role of Radiosurgery/Stereotactic Radiotherapy in Oligometastatic Disease: Brain Oligometastases
por: Mazzola, Rosario, et al.
Publicado: (2019)

Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Spine Metastases: An Overview
por: Zeng, Kang Liang, et al.
Publicado: (2019)

Extracranial Stereotactic Body Radiotherapy in Oligometastatic or Oligoprogressive Breast Cancer
por: Weykamp, Fabian, et al.
Publicado: (2020)

Precision Stereotactic Radiotherapy for Spinal Tumors: Mechanism, Efficacy, and Issues
por: Zhuang, Hongqing, et al.
Publicado: (2020)

Feasibility, safety, and efficacy of circumferential spine stereotactic body radiotherapy
por: Dibs, Khaled, et al.
Publicado: (2022)

Dose surface maps of the heart can identify regions associated with worse survival for lung cancer patients treated with radiotherapy
por: McWilliam, Alan, et al.
Publicado: (2020)

Enhancement of Long-Term External–Internal Correlation by Phase-Shift Detection and Correction Based on Concurrent External Bellows and Internal Navigator Signals
por: Milewski, Andrew R., et al.
Publicado: (2019)

Cardiac Toxicity of Thoracic Radiotherapy: Existing Evidence and Future Directions
por: Banfill, Kathryn, et al.
Publicado: (2021)

Stereotactic radiosurgery and stereotactic radiotherapy for brain metastases
por: Halasz, Lia M., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_bcle26jvf9karl8m6pbss2vnev